Health & Medical Cancer & Oncology

Drug Shows Promise Against Advanced Lung Cancer

Drug Shows Promise Against Advanced Lung Cancer

Drug Shows Promise Against Advanced Lung Cancer


Patients given nivolumab reported fewer side effects, longer survival than those receiving usual chemo agent

"If a person can be treated for a few months and then remain off treatment for a year, that may be a more cost-effective method of treatment than standard chemotherapy," he said.

Data and conclusions presented at meetings are usually considered preliminary until published in a peer-reviewed medical journal.

 

Leave a reply